title: Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid.
authors.forename: M
authors.initials: M
authors.lastname: Zirbs
authors.forename: E
authors.initials: E
authors.lastname: Kigitsidou
authors.forename: F
authors.initials: F
authors.lastname: Seifert
authors.forename: J
authors.initials: J
authors.lastname: Ring
authors.forename: K
authors.initials: K
authors.lastname: Brockow
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; D000069285:Infliximab; D007538:Isoniazid